Helios Cardio
MA - WestonBiotechnology
Focus: Helios Cardio is a public biotechnology company headquartered in Weston, MA, specializing in regenerative biologic matrices for cardiovascular and oncology applications. The company is in early-stage clinical development with a focused pipeline centered on CardMend technology.
Profile data last refreshed 6h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
2
Should You Work at Helios Cardio?
AI assessmentHelios Cardio is a speculative early-stage play for scientists/engineers seeking deep technical work in regenerative medicine, but offers limited near-term career stability or growth opportunities.
Why Work Here
- Early-stage regenerative medicine platform with potential to pioneer a new therapeutic modality in cardiology, offering exposure to cutting-edge biotech science
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CardiaMend in Combination with Amiodarone
Atrial FibrillationClinical Trials (1)
NCT06063538Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone
Phase 1Help build intelligence for Helios Cardio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.